Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07594119
PHASE3

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-2

Sponsor: Rapport Therapeutics Inc.

View on ClinicalTrials.gov

Summary

This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.

Official title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

312

Start Date

2026-09-01

Completion Date

2029-09

Last Updated

2026-11-20

Healthy Volunteers

No

Interventions

DRUG

RAP-219

RAP-219 medium dose tablets administered orally daily

DRUG

RAP-219

RAP-219 low dose tablets administered orally daily

OTHER

Placebo

Matching placebo tablets administered orally

Locations (17)

Clinical Study Center

Huntsville, Alabama, United States

Clinical Study Center

Bentonville, Arkansas, United States

Clinical Study Center

Colorado Springs, Colorado, United States

Clinical Study Center

Maitland, Florida, United States

Clinical Study Center

Miami, Florida, United States

Clinical Study Center

Honolulu, Hawaii, United States

Clinical Study Center

Chicago, Illinois, United States

Clinical Study Center

Omaha, Nebraska, United States

Clinical Study Center

New York, New York, United States

Clinical Study Center

Raleigh, North Carolina, United States

Clinical Study Center

Portland, Oregon, United States

Clinical Study Center

Nashville, Tennessee, United States

Clinical Study Center

Houston, Texas, United States

Clinical Study Center

Melbourne, Australia

Clinical Study Center

Seoul, South Korea

Clinical Study Center

Cornwell, United Kingdom

Clinical Study Center

London, United Kingdom